EUVIMED · CrossrefJournal
Chinese Journal of Cancer Research
ISSN 1000-9604 · Chinese Journal of Cancer Research
Latest articles
Expert consensus on multidisciplinary management of laparoscopic-endoscopic cooperative surgery combined with sentinel lymph node navigation surgery for early gastric cancer (2026 edition)
Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort study
Chemotherapy-free regimen: Real-world efficacy and safety of anlotinib plus PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer
Dynamic income patterns and risk of pancreatic and biliary tract cancers: A nationwide cohort study
Circulating tumor cells with chromosome 8 aneuploidy are a diagnostic and prognostic monitoring biomarker for ovarian cancer
Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway
Frontiers in bacterial outer membrane vesicles: From basic characteristics to cancer therapy
Preface to Special Issue: AI-driven comprehensive cancer therapy: Strategy construction, basic and translational research
Artificial intelligence empowered biomaterials for cancer therapy: From rational design to clinical translation
Current trends and future directions of artificial intelligence in lung cancer diagnosis
Integrating AI-driven single-cell analysis to decode epithelial heterogeneity: A prognostic signature and translational immunotherapy strategy targeting KRT18-induced PD-L1 in lung adenocarcinoma
CARE framework: Rethinking randomized controlled trials for medical artificial intelligence
From spatial maps to therapeutic targets: Next challenge for artificial intelligence in cancer spatial omics
Cross-domain few-shot learning: A new perspective on overcoming bottlenecks in clinical artificial intelligence tumor diagnosis
Revisiting nature of stage III non-small cell lung cancer: Anatomically defined, biologically systemic
Refined immune-based molecular subtypes of gastric cancer: Integrating mismatch repair status and tumor microenvironment for enhanced immunotherapy prediction
Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer
Novel germline JAK2 L808W and E305Vfs*4 mutations in familial essential thrombocythemia: Evidence from two pedigrees
Preface to Special Issue: Breakthroughs in malignancy therapy: New advances and emerging trends—Awakening immune system: The new era of radioimmunotherapy
Breakthroughs of chimeric antigen receptor T-cell therapy in hematological malignancies: From ex vivo to in vivo
Turmoil and breakthroughs: Highlights and growing pains in breast cancer therapy 2025−2026
Managing evolution of metastatic prostate cancer: From hormone-sensitive to castration-resistant disease
Gastric cancer surgery in the era of neoadjuvant immunotherapy
Tumor-metabolism integrated therapy: A new paradigm for fertility-sparing treatment in endometrial cancer
Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma
Immune decoding from a multi-omics perspective: Redefining pancreatic cancer tumor microenvironment
Updates of CSCO guidelines for diagnosis and treatment of lymphoma: 2026 edition
Is sentinel node navigation surgery feasible after non-curative endoscopic resection in patients with early gastric cancer?
Rethinking false-negative rate of sentinel node navigation surgery after non-curative endoscopic submucosal dissection: Insights from SENORITA 2 trial
Early prediction of synergistic cardiotoxicity induced by PD-1 inhibitors and doxorubicin using cardiac18F-FDG PET/MRI
Volumes
2026 · 582025 · 802024 · 562023 · 562022 · 472021 · 642020 · 342019 · 872018 · 692017 · 702016 · 592012 · 642011 · 592010 · 492009 · 502008 · 572007 · 592006 · 582005 · 632004 · 642003 · 662002 · 672001 · 712000 · 761999 · 851998 · 721997 · 721996 · 791995 · 651994 · 541993 · 581992 · 531991 · 631990 · 641989 · 481988 · 16
EUVIMED